These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 14747532)

  • 21. Th2 cell differentiation from naive CD4
    Hirata H; Yukawa T; Tanaka A; Miyao T; Fukuda T; Fukushima Y; Kurasawa K; Arima M
    Clin Exp Allergy; 2019 Apr; 49(4):474-483. PubMed ID: 30431203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
    Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
    J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells.
    Fujita H; Asahina A; Sugaya M; Nakamura K; Gao P; Fujiwara H; Tamaki K
    J Invest Dermatol; 2005 Feb; 124(2):343-50. PubMed ID: 15675953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1.
    Uchihara JN; Krensky AM; Matsuda T; Kawakami H; Okudaira T; Masuda M; Ohta T; Takasu N; Mori N
    Int J Cancer; 2005 May; 114(5):747-55. PubMed ID: 15609310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines.
    Lai HC; Hsiao JR; Chen CW; Wu SY; Lee CH; Su IJ; Takada K; Chang Y
    Virology; 2010 Sep; 405(2):464-73. PubMed ID: 20637487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
    Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
    Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
    Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation.
    Lebre MC; Burwell T; Vieira PL; Lora J; Coyle AJ; Kapsenberg ML; Clausen BE; De Jong EC
    Immunol Cell Biol; 2005 Oct; 83(5):525-35. PubMed ID: 16174103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors.
    Kobayashi M; Shimauchi T; Hino R; Tokura Y
    Cell Immunol; 2004 Mar; 228(1):27-33. PubMed ID: 15203317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
    Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
    Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells.
    Penna G; Vulcano M; Roncari A; Facchetti F; Sozzani S; Adorini L
    J Immunol; 2002 Dec; 169(12):6673-6. PubMed ID: 12471096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCL17 and CCL22 attenuate CCL5-induced mast cell migration.
    Juremalm M; Olsson N; Nilsson G
    Clin Exp Allergy; 2005 Jun; 35(6):708-12. PubMed ID: 15969658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomas.
    Maggio EM; Van Den Berg A; Visser L; Diepstra A; Kluiver J; Emmens R; Poppema S
    Int J Cancer; 2002 Jun; 99(5):665-72. PubMed ID: 12115499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
    Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.
    Malhotra P; Haslett P; Sherry B; Shepp DH; Barber P; Abshier J; Roy U; Schmidtmayerova H
    Sci Rep; 2019 Apr; 9(1):5963. PubMed ID: 30979916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
    Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
    J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H; Takahashi M; Nakamura K; Kaneko F
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission.
    Marshall NA; Culligan DJ; Johnston PW; Millar C; Barker RN; Vickers MA
    Br J Haematol; 2007 Oct; 139(1):81-9. PubMed ID: 17854310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.